NCT04022187

Brief Summary

Spasticity is commonly observed in neurological conditions such as Multiple Sclerosis and spinal cord injury. "Peripheral" spasticity, concerning in particular the striated muscles of the limbs is nowadays well known and studied with clinical scales (Ashworth, Taridieu...) or even electrophysiological methods (H-reflex, T-reflex...). However, this spasticity can also affect the perineal muscles and more generally the pelvic muscles. However, there is to date no validated and standardized method for evaluating this pelvi-perineal spasticity. The aim of the study will be to assess the spinal motoneurons excitability by using the stimulus-response curves of the bulbocavernosus reflex.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 11, 2019

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2019

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 17, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

February 18, 2022

Status Verified

February 1, 2022

Enrollment Period

Same day

First QC Date

July 13, 2019

Last Update Submit

February 17, 2022

Conditions

Keywords

Bulbocavernosus reflexSpasticity assessmentMotoneurone excitabilityStimulus-response curves

Outcome Measures

Primary Outcomes (1)

  • Variation of the recruitment slope according to the degree of bladder repletion

    For each patient, an assessment of spinal motoneuron excitability by using the area under the motor response curve of the bulbocavernous reflex will be performed before starting the cystometry (empty bladder) and during urgent urination needs (also during the cystometry) to determine an alpha angle of the recruitment curve. The primary outcome is the variation in this alpha coefficient.

    1 day

Secondary Outcomes (2)

  • Comparison of the variation of recruitment slope according to the bladder repletion : (empty bladder - B1) versus (B1-B3) variation

    1 day

  • Influence of neurological disease on spinal motoneuron excitability

    1 day

Study Arms (1)

Bulbocavernosus reflex assessment

Patients over 18 years old, consulting in neuro-urology department for urinary, anorectal or genito-sexual disorders.

Other: Observational study : no intervention

Interventions

Observational study : no intervention, only exporting data

Bulbocavernosus reflex assessment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients who will be referred to our specialized neuro-urology service for electrophysiological and urodynamic explorations

You may qualify if:

  • years old minimum
  • Subjects with spinal cord injury or multiple sclerosis, requiring an electrophysiological and urodynamic explorations in our neuro-urology specialized department, with a strictly supra-sacral central neurological condition.
  • Subjects with stress urinary incontinence (SUI) requiring perineal explorations including a cystometry and a perineal EMG.

You may not qualify if:

  • Subjects with peripheral neurological impairment (cauda equina syndrome, medullary cone syndrome, advanced diabetes)
  • Subjects who received a treatment by injection of intra-detrusorian botulinum toxin in the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of neuro-urology, hôpital Tenon

Paris, 75020, France

Location

MeSH Terms

Conditions

Muscle Spasticity

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gérard Amarenco, PHD

    Sorbonne Université, GRC 001, GREEN, AP-HP, Hôpital Tenon, Paris, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Neuro-Urology department, Tenon Hospital

Study Record Dates

First Submitted

July 13, 2019

First Posted

July 17, 2019

Study Start

July 11, 2019

Primary Completion

July 11, 2019

Study Completion

September 30, 2019

Last Updated

February 18, 2022

Record last verified: 2022-02

Locations